Study of the B- and T-lymphocyte responses in pemphigus patients treated by anti-CD20 immunotherapy (Rituximab)

被引：0
|
作者：
Musette, P
Mouquet, H
Jacquot, S
Gilbert, D
Huetz, F
Roujeau, JC
D'Incan, M
Tron, F
Joly, P
机构：
[1] INSERM U519, Paris, France
[2] Inst Pasteur, Paris, France
[3] CHU Creteil, Creteil, France
[4] CHU Clermont Ferrand, Clermont Ferrand, France
[5] CHU Rouen, Rouen, France
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2005年 / 125卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
076
引用
收藏
页码：A13 / A13
页数：1
相关论文
共 50 条
  • [1] Study of the B- and T-lymphocyte responses in pemphigus patients treated by anti-CD20 immunotherapy (rituximab)
    Musette, P.
    Mouquet, H.
    Jacquot, S.
    Gilbert, D.
    Gougeon, M. L.
    Roujeau, J. C.
    D'Incan, M.
    Bedane, C.
    Tron, F.
    Joly, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 23 - 23
  • [2] Study of the B- and T-lymphocyte responses in pemphigus patients treated by anti-CD20 immunotherapy (Rituximab).
    Musette, P
    Mouquet, H
    Jacquot, S
    Gilbert, D
    Huetz, F
    Roujeau, JC
    D'Incan, M
    Doutre, MS
    Gorin, I
    Caux, F
    Bedane, C
    Oro, S
    Tron, F
    Joly, P
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (06) : A16 - A16
  • [3] A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): Factors associated with B lymphocyte recovery
    Sutter, Jennifer A.
    Kwan-Morley, Jennifer
    Dunham, Jon
    Du, Yang-Zhu
    Kamoun, Malek
    Albert, Daniel
    Eisenberg, Robert A.
    Prak, Eline T. Luning
    CLINICAL IMMUNOLOGY, 2008, 126 (03) : 282 - 290
  • [4] Treatment with rituximab (anti-CD20) affects both autoreactive T and B lymphocytes in pemphigus vulgaris
    Eming, R.
    Nagel, A.
    Wolff-Franke, S.
    Podstawa, E.
    Hertl, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 22 - 22
  • [5] Anti-CD20 (rituximab) treatment of pemphigus vulgaris affects both autoaggressive B and T lymphocytes
    Eming, R
    Nagel, A
    Wolff-Franke, S
    Veldman, C
    Hertl, M
    EXPERIMENTAL DERMATOLOGY, 2006, 15 (03) : 204 - 204
  • [6] Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus
    Arin, MJ
    Engert, A
    Krieg, T
    Hunzelmann, N
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (03) : 620 - 625
  • [7] Treatment of pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab)
    Herrmann, G
    Engert, A
    Hunzelmann, N
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (03) : 602 - 603
  • [8] Treatment of refractory pemphigus with the anti-CD20 monoclonal antibody (rituximab)
    Marzano, Angelo V.
    Fanoni, Daniele
    Venegoni, Luigia
    Berti, Emilio
    Caputo, Ruggero
    DERMATOLOGY, 2007, 214 (04) : 310 - 318
  • [9] Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (Rituximab)
    Cooper, HL
    Healy, E
    Theaker, JM
    Friedmann, PS
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2003, 28 (04) : 366 - 368
  • [10] Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)
    Morrison, LH
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (05) : 817 - 819
12345